Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹205 Cr₹84 Cr₹57 Cr₹24 Cr₹24 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹205 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr
Mar2021₹24 Cr
Mar2020₹24 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr
140.72
Mar2021 ₹24 Cr
-1.88
Mar2020 ₹24 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,096.6 Cr 1.7% -15.4% 57.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,974.0 Cr 1.3% -4.7% 22.8% Stock Analytics
DIVIS LABORATORIES ₹161,729.0 Cr 6.3% 3.3% 59.2% Stock Analytics
CIPLA ₹116,999.0 Cr -0.7% -3.3% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,771.0 Cr 2.1% -9.7% -0.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,951.9 Cr 2.1% -2.8% 26.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.7%

-15.4%

57.7%

SENSEX

2.7%

0.8%

9.7%


You may also like the below Video Courses